184 related articles for article (PubMed ID: 2736533)
1. Simultaneous measurement of progesterone receptors and DNA indices by flow cytometry: characterization of an assay in breast cancer cell lines.
Graham ML; Bunn PA; Jewett PB; Gonzalez-Aller C; Horwitz KB
Cancer Res; 1989 Jul; 49(14):3934-42. PubMed ID: 2736533
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous measurement of progesterone receptors and DNA indices by flow cytometry: analysis of breast cancer cell mixtures and genetic instability of the T47D line.
Graham ML; Dalquist KE; Horwitz KB
Cancer Res; 1989 Jul; 49(14):3943-9. PubMed ID: 2660983
[TBL] [Abstract][Full Text] [Related]
3. New T47D breast cancer cell lines for the independent study of progesterone B- and A-receptors: only antiprogestin-occupied B-receptors are switched to transcriptional agonists by cAMP.
Sartorius CA; Groshong SD; Miller LA; Powell RL; Tung L; Takimoto GS; Horwitz KB
Cancer Res; 1994 Jul; 54(14):3868-77. PubMed ID: 8033109
[TBL] [Abstract][Full Text] [Related]
4. Heterogeneity of progesterone receptor content and remodeling by tamoxifen characterize subpopulations of cultured human breast cancer cells: analysis by quantitative dual parameter flow cytometry.
Graham ML; Smith JA; Jewett PB; Horwitz KB
Cancer Res; 1992 Feb; 52(3):593-602. PubMed ID: 1732047
[TBL] [Abstract][Full Text] [Related]
5. Immunocytochemical localization of progesterone receptors in breast cancer with anti-human receptor monoclonal antibodies.
Elashry-Stowers D; Zava DT; Speers WC; Edwards DP
Cancer Res; 1988 Nov; 48(22):6462-74. PubMed ID: 3180062
[TBL] [Abstract][Full Text] [Related]
6. Cell kinetic analysis of mixed populations using three-color fluorescence flow cytometry.
Begg AC; Hofland I
Cytometry; 1991; 12(5):445-54. PubMed ID: 1718673
[TBL] [Abstract][Full Text] [Related]
7. [Western blot analysis and flow cytometric analysis of estrogen and progesterone receptors in fixed breast cancer cells].
Tao DD; Jiang M; Wu JH; Feng YD; Gong JP
Ai Zheng; 2004 Mar; 23(3):339-41. PubMed ID: 15025971
[TBL] [Abstract][Full Text] [Related]
8. Flow cytometry: a new approach for the molecular profiling of breast cancer.
Lostumbo A; Mehta D; Setty S; Nunez R
Exp Mol Pathol; 2006 Feb; 80(1):46-53. PubMed ID: 16271361
[TBL] [Abstract][Full Text] [Related]
9. Progesterone receptor detection and quantification in breast tumors by bivariate immunofluorescence/DNA flow cytometry.
Remvikos Y; VuHai M; Lainé-Bidron C; Jollivet A; Magdelénat H
Cytometry; 1991; 12(2):157-66. PubMed ID: 2049973
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous analysis of cell cycle kinetics at two different DNA ploidy levels based on DNA content and cyclin B measurements.
Gong J; Traganos F; Darzynkiewicz Z
Cancer Res; 1993 Nov; 53(21):5096-9. PubMed ID: 8221643
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous measurement of two cellular antigens and DNA using fluorescein-isothiocyanate, R-phycoerythrin, and propidium iodide on a standard FACScan.
Corver WE; Cornelisse CJ; Fleuren GJ
Cytometry; 1994 Feb; 15(2):117-28. PubMed ID: 8168399
[TBL] [Abstract][Full Text] [Related]
12. Cell-cycle studies by multiparametric automatic scanning of topographically preserved cells in culture.
Colomb E; Kopp F; Spyratos F; Martin PM
Cytometry; 1989 May; 10(3):263-72. PubMed ID: 2714110
[TBL] [Abstract][Full Text] [Related]
13. p53-dependent inhibition of progestin-induced VEGF expression in human breast cancer cells.
Liang Y; Wu J; Stancel GM; Hyder SM
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):173-82. PubMed ID: 15860260
[TBL] [Abstract][Full Text] [Related]
14. Immunocytochemical study with monoclonal antibodies to progesterone receptor in human breast tumors.
Perrot-Applanat M; Groyer-Picard MT; Lorenzo F; Jolivet A; Vu Hai MT; Pallud C; Spyratos F; Milgrom E
Cancer Res; 1987 May; 47(10):2652-61. PubMed ID: 2436753
[TBL] [Abstract][Full Text] [Related]
15. Prognostic indicators including DNA histogram type, receptor content, and staging related to human breast cancer patient survival.
Coulson PB; Thornthwaite JT; Woolley TW; Sugarbaker EV; Seckinger D
Cancer Res; 1984 Sep; 44(9):4187-96. PubMed ID: 6744328
[TBL] [Abstract][Full Text] [Related]
16. A method for simultaneous nuclear immunofluorescence and DNA content quantitation using monoclonal antibodies and flow cytometry.
Clevenger CV; Bauer KD; Epstein AL
Cytometry; 1985 May; 6(3):208-14. PubMed ID: 3888556
[TBL] [Abstract][Full Text] [Related]
17. Immunofluorescent localization of a novel progesterone receptor(s) in a T47D-Y breast cancer cell line lacking genomic progesterone receptor expression.
Price TM; Hansen EL; Oliver TN
J Soc Gynecol Investig; 2005 Dec; 12(8):610-6. PubMed ID: 16325750
[TBL] [Abstract][Full Text] [Related]
18. Flow cytometry of mitotic cells.
Anderson HJ; de Jong G; Vincent I; Roberge M
Exp Cell Res; 1998 Feb; 238(2):498-502. PubMed ID: 9473359
[TBL] [Abstract][Full Text] [Related]
19. Reduction of human metastatic breast cancer cell aggressiveness on introduction of either form a or B of the progesterone receptor and then treatment with progestins.
Sumida T; Itahana Y; Hamakawa H; Desprez PY
Cancer Res; 2004 Nov; 64(21):7886-92. PubMed ID: 15520195
[TBL] [Abstract][Full Text] [Related]
20. Characterization of estrogen and progesterone receptors and the dissociated regulation of growth and progesterone receptor stimulation by estrogen in MDA-MB-134 human breast cancer cells.
Reiner GC; Katzenellenbogen BS
Cancer Res; 1986 Mar; 46(3):1124-31. PubMed ID: 3943090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
